J. Michael Millis

Last updated
James Michael Millis
NationalityAmerican
Occupation(s)Surgeon, academic
AwardsHippocrates Award
Global Citizen Hero Award from Red Cross
Academic background
EducationB.A. in Chemistry and Political Science
M.D.
Alma mater University of Tennessee, College of Medicine
Emory University

James Michael Millis is an American academic and surgeon specializing in pediatric and adult liver transplantation. [1] He is Professor of Surgery and Vice Chair of Global Surgery at University of Chicago. [2] He is also the director of Clinical Leadership Development Fellowship and Hepatobiliary Surgery at the University of Chicago Medical Center. He is known for developing new techniques of liver surgery that improved outcomes following liver transplantation and non transplant liver and biliary tract surgery. [3]

Contents

Education

Millis graduated with a B.A. in Chemistry and Political Science from Emory University in 1981. Later, he completed his M.D. from University of Tennessee in 1985 and joined the University of California at Los Angeles as a surgery intern. In 1987, he also started research in liver transplantation at UCLA, becoming the Dumont Transplant Fellow at the institute in 1992. At the same time, he was an instructor in surgery at UCLA. In 2014, he received an MBA from University of Massachusetts, Amherst. [4]

Career

Millis left UCLA in 1994 to join the University of Chicago as assistant professor in Department of Surgery, becoming associate professor in 1997 and professor in 2002. [3]

In 1994, he also joined the University of Chicago Hospitals. In 1997, he was appointed the director of Pediatric Liver Transplant Program and Liver Transplant Program at University of Chicago Hospitals. [1] He stepped down from the position of director at the Liver Transplant Program in 2006, being appointed again as the director of the program in 2014. From 2000 to 2016, he was the Chief of Section of Transplant Surgery at University of Chicago. [5] In 2008, he founded the Transplant Center at University of Chicago Medical Center and led the center until 2016, stepping down to focus on his international efforts of improving surgical care and ethics, establishing the Global Surgery Program at the University of Chicago. [6]

Millis has done significant work in the area of global surgery, hosting dozens of physicians and scientists from China and other countries around the world desiring experience in the United States. He developed the Clinical Leadership Development Fellowship program at University of Chicago that provides people from other countries the training to lead clinical health care enterprises. [7] He has hosted dozens of Chinese students, residents and faculty at the University of Chicago to provide them with first-hand knowledge of the delivery of surgical care at leading academic health centers. He has also facilitated visits by US residents, fellows and faculty to Chinese centers to broaden their exposure and experience. In 2015, he was appointed the Vice Chair of Global Surgery at the University of Chicago. [8] [9]

In 2015, he became a senior faculty scholar at Bucksbaum Institute for Clinical Excellence [10] and in 2017 a faculty member at the MacLean Center for Clinical Medical Ethics. [11]

Millis serves on the editorial board of many scientific journals in the field of transplantation and surgery including World Journal of Gastroenterology and Journal of Gastrointestinal Surgery. [12] He is also the co-editor of Hepatobiliary Surgery and Nutrition. [13]

Research

Millis has also conducted researching exploring how cellular technology can be applied to patient care. He has organized many national and international conferences on the topics ranging from violence in healthcare to surgical research. [9]

Healthy policy and ethics

A significant part of Millis's research has focused on policy and ethics in the field of health; and implementing ethical standards as the field of surgery becomes global. In 2006, he, with support of the China Medical Board, worked with Jiefu Huang, then the vice minister of health of China, to establish regulations governing the practice of transplantation in China and improve the outcomes and ethical standards of the transplantationin China. They initiated reforms that paved the way for banning transplant tourism and buying and selling of organs. They further established the requirements for transplant procedures including surgeon experience and ICU requirements. [1]

Millis and Huang initiated a pilot program in China that allowed for voluntary organ donation. Upon the success of the program, it was expanded nationally. Later, in January 2018, the use of organs from executed donors was also banned in China. Their work changed the entire policy of transplantation in China. Millis also organized several conferences in China on the issues of ethics in healthcare in international settings. [14] [15]

In 2016, he helped the Peking Union Medical College Hospital in reforming their GME into a competency and milestone-based curriculum from their apprentice based system. [16]

Recognition

Millis received the Hippocrates Award in 2012, and the Global Citizen Hero Award from Red Cross. [17]

Selected publications

Books

Book chapters

Articles

Related Research Articles

<span class="mw-page-title-main">Organ transplantation</span> Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

<span class="mw-page-title-main">Liver transplantation</span> Type of organ transplantation

Liver transplantation or hepatic transplantation is the replacement of a diseased liver with the healthy liver from another person (allograft). Liver transplantation is a treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. The most common technique is orthotopic transplantation, in which the native liver is removed and replaced by the donor organ in the same anatomic position as the original liver. The surgical procedure is complex, requiring careful harvest of the donor organ and meticulous implantation into the recipient. Liver transplantation is highly regulated, and only performed at designated transplant medical centers by highly trained transplant physicians and supporting medical team. The duration of the surgery ranges from 4 to 18 hours depending on outcome. Favorable outcomes require careful screening for eligible recipient, as well as a well-calibrated live or cadaveric donor match.

Dr. A. M. James Shapiro is a British-Canadian surgeon best known for leading the clinical team that developed the Edmonton Protocol – an islet transplant procedure for the treatment of type 1 diabetes. Dr. Shapiro is Professor of Surgery, Medicine, and Surgical Oncology at the University of Alberta and the Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program with Alberta Health Services.

<span class="mw-page-title-main">Organ transplantation in China</span>

Organ transplantation in China has taken place since the 1960s, and is one of the largest organ transplant programmes in the world, peaking at over 13,000 liver and kidney transplants a year in 2004.

<span class="mw-page-title-main">Hepatoportoenterostomy</span>

A hepatoportoenterostomy or Kasai portoenterostomy is a surgical treatment performed on infants with Type IVb choledochal cyst and biliary atresia to allow for bile drainage. In these infants, the bile is not able to drain normally from the small bile ducts within the liver into the larger bile ducts that connect to the gall bladder and small intestine.

Tomoaki Kato is a pioneer in multiple-organ transplantation, pediatric and adult liver transplantation. Kato is Surgical Director of Adult and Pediatric Liver and Intestinal Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center and is a professor of surgery at Columbia University College of Physicians and Surgeons. Kato is also known for unique and innovative surgeries for adults and children, including a six-organ transplant; a procedure called APOLT that resuscitates a failing liver by attaching a partial donor liver, making immunosuppressant drugs unnecessary; and the first successful human partial bladder transplantation involving the transplant of two kidneys together with ureters connected to a patch of the donor bladder. In a highly publicized case, he led the first reported removal and re-implantation, or auto-transplantation, of six organs to excise a hard-to-reach abdominal tumor. Previously the director of pediatric liver and gastrointestinal transplant and professor of clinical surgery at the University of Miami School of Medicine, Kato received his medical degree from the Osaka University Medical School in Japan and received his residency training in surgery at Osaka University Hospital and Itami City Hospital in Hyogo, Japan. He completed a clinical fellowship in transplantation at the University of Miami/Jackson Memorial Hospital, in Miami, Florida, where he was subsequently appointed to the surgical faculty in 1997, and promoted to full professor in 2007. He served as a surgeon and senior leader of the liver and transplantation center at Miami's Jackson Memorial Hospital, beginning in 1997, and at University of Miami Hospital, beginning in 2004. Kato is a member of numerous professional and honorary organizations, and the author or co-author of more than 180 scientific papers in peer-reviewed journals.

<span class="mw-page-title-main">Arvinder Singh Soin</span> Indian hepatologists

Dr. Arvinder Singh Soin is the Chief Hepatobiliary and Liver Transplant Surgeon & Chairman of the Institute of Liver Transplantation and Regenerative Medicine, Medanta-The Medicity, India. A surgeon and pioneer in the field of liver transplantation, acknowledged for his work in establishing liver transplantation in India. Dr. Soin also runs the Liver Transplant institute at the Sir H. N. Reliance Foundation Hospital, Mumbai. Dr Soin has performed more than 3500 living donor liver transplants in India, which is the highest in the country, and the second-highest in the world.

Sander S. Florman is an American transplant surgeon and Director of the Recanati/Miller Transplantation Institute at The Mount Sinai Hospital in New York City. He is a member of the American Society of Transplant Surgeons, the American Hepato-Pancreato-Biliary Association, the American Society of Transplantation and the American College of Surgeons.

<span class="mw-page-title-main">Francis L. Delmonico</span>

Francis L. Delmonico, MD, FACS is a surgeon, clinical professor and health expert in the field of transplantation. He serves on numerous committees and is affiliated with various leading organizations and institutions. He is the chief medical officer of the New England Organ Bank (NEOB) and Professor of Surgery, Part-Time at Harvard Medical School in Boston, Massachusetts, where he is emeritus director of renal transplantation. He served as president of The Transplantation Society (TTS) from 2012 to 2014, an international non-profit organization based in Montreal, Canada that works with international transplantation physicians and researchers. He also served as the president of the United Network of Organ Sharing (UNOS) in 2005, which overseas the practice of organ donation and transplantation in the United States. He was appointed and still serves as an advisor to the World Health Organization in matters of organ donation and transplantation. He was appointed by Pope Francis to the Pontifical Academy of Science in 2016. In 2020, he became the recipient of the Medawar Prize of The Transplantation Society.

MIRA is a multidisciplinary and complementary method for treating many chronic diseases. The MIRA Procedure is a result of combining efforts from different medical fields developed in the University of Chicago in 1992. It basically consists in medically grafting live rejuvenated tissue in the form of autologous adipose adult stem cells to a damaged organ in order to restore it and improve its function. This method is currently approved by the U.S. Food and Drug Administration (FDA).

The MacLean Center for Clinical Medical Ethics, founded in 1981, is a non-profit clinical medical ethics research institute based in the United States. Founded by its director, Mark Siegler, the MacLean Center for Clinical Medical Ethics aims to improve patient care and outcomes by promoting research in clinical medical ethics by educating physicians, nurses, and other health care professionals and by helping University of Chicago Medicine patients, families, and health care providers identify and resolve ethical dilemmas. The center has trained over 410 fellows, including many physicians, attorneys, PhDs and bioethicists.

<span class="mw-page-title-main">Subash Gupta</span>

Dr Subhash Gupta is the chief of liver transplantation, a hepato-pancreato-biliary surgeon, and the chairman of the Max Center of Liver and Biliary Sciences at Max Healthcare, Saket.

Olivier James Garden, is a British surgeon and academic. He holds the Regius Chair of Clinical Surgery at the University of Edinburgh and the president of the International Hepato-Pancreato-Biliary Association from 2012 to 2014. Garden performed Scotland's first liver transplant in Edinburgh in 1992 and founded the Scottish Liver Transplant Programme.

<span class="mw-page-title-main">Lainie Friedman Ross</span> American physician and bioethicist

Lainie Friedman Ross is an American physician and bioethicist who works at the University of Chicago.

J. Michael Henderson is an American general and transplant surgeon, with experience in portal hypertension, liver transplantation, and pancreatic disease. Henderson is the Chief Medical Officer at the University of Mississippi Medical Center since 2015. Prior to this role, he was with the Cleveland Clinic from 1992–2014. He was the Chairman of the Department of General Surgery and Director of the Transplant Center for 12 years, and was the Chief Quality Officer for the Cleveland Clinic’s 10-hospital system for eight years.

<span class="mw-page-title-main">Morio Kasai</span> Japanese pediatric surgeon

Morio Kasai was a Japanese surgeon who had a strong interest in pediatric surgery. While Kasai went into practice at a time when pediatric surgery was not an established subspecialty, much of his clinical and research work was related to the surgical care of children. He is best known for devising a surgical procedure, the hepatoportoenterostomy, to address a life-threatening birth defect known as biliary atresia. The modern form of the operation is still known as the Kasai procedure.

Chen Chao-long is a Taiwanese transplant surgeon.

Ernesto Pompeo Molmenti is an American transplant surgeon, scientist, and author. Currently practicing in Long Island, New York. He is Chief of Surgical Innovation and Vice-Chairman of the Department of Surgery at North Shore University Hospital / Northwell Health, and Professor of Surgery, Medicine, and Pediatrics at Zucker School of Medicine at Hofstra/Northwell. He is known for his description of the “Syndromic Incidence of Ovarian Cancer after Liver Transplantation, with Special Reference to Anteceding Breast Cancer,” and for the development of the vascular reconstruction technique that has been named "Molmenti technique".

Doctor Dong Jiahong is a Chinese surgeon specialising in liver transplantation. Dong is the president of Beijing Tsinghua Changgung Hospital, president of the Clinical Medicine School in Tsinghua University, and president of the Society for Hepatopancreatobiliary Surgery in the Chinese Research Hospital Association. He also serves as a committee member of the Chinese Surgical Association and the Chinese Transplantation Association, an executive councillor of the International Society of Digestive Surgery (ISDS), a scientific committee member of the International HPB Association (IHPBA), and honorary foreign member of the French National Academy of Surgery, the American Surgical Association, and the European Surgical Association.

Russell Walker Strong, is an Australian transplant surgeon. He pioneered several techniques for liver transplantation, including reduced-size liver transplantation, split-liver transplantation, and living donor liver transplantation.

References

  1. 1 2 3 "Meet the local doctor who helped end China's corrupt organ-transplant system". Chicago Business. 9 December 2015.
  2. ↑ "J. Michael Millis, MD". University of Chicago Medicine.
  3. 1 2 "Trial begins for first artificial liver device using human cells". University of Chicago Medicine.
  4. ↑ "J. Michael Millis". University of Chicago.
  5. ↑ "Global Surgery Program".
  6. ↑ Grady, Denise (22 February 2010). "Liver Transplants That Do Their Job, Then Fade Away". The New York Times.
  7. ↑ "China-US Conference on Clinical Ethics Consultation". University of Chicago.
  8. ↑ "Dr. Michael Millis Takes on Corrupt Chinese Organ Transplant System". Archived from the original on 2019-07-05. Retrieved 2019-07-05.
  9. 1 2 "曝光：邪恶的肝胆外科及论文写作国际研讨会". University of Chicago. Archived from the original on 2019-07-05. Retrieved 2019-07-05.
  10. ↑ "Senior Faculty Scholars - Bucksbaum Institute for Clinical Excellence". Bucksbaum Institute. Archived from the original on 2019-07-05. Retrieved 2019-07-05.
  11. ↑ "Our Faculty and Staff". The MacLean Center.
  12. ↑ "Editorial Board". Springer.
  13. ↑ "Editorial Team". Hepatobiliary Surgery and Nutrition.
  14. ↑ "China used to harvest organs from prisoners. Under pressure, that practice is finally ending". The Washington Post .
  15. ↑ "全球生物人工肝领军人物J•Michael•Millis教授与公司领导一行莅临光谷生物城考察交流". Wuhan Tong Stem Medical Polytron Technologies.[ permanent dead link ]
  16. ↑ "Hepatobiliary, Pancreatic Surgery and Manuscript Writing Symposium". University of Chicago.
  17. ↑ "UChicago Medicine 2017 Department of Surgery Annual Report". The Constant.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.